IndraLab

Statements


USP2 inhibits TNFSF10. 3 / 3
| 3

reach
"The pharmacological inhibitor (ML364) and siRNA targeting USP2 enhanced TNF-related apoptosis-inducing ligand (TRAIL)-induced cancer cell death, but not normal cells."

reach
"These data suggested that survivin contributes to depletion of USP2-mediated TRAIL sensitization."

reach
"Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin."